Paratesticular Dedifferentiated Liposarcoma (DDL): A Clinicopathologic Study and Analysis of MDM-2 Expression in 29 Cases

被引：0
|
作者：
Kryvenko, O. N.
Epstein, J. I.
机构：
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
943
引用
收藏
页码：227A / 227A
页数：1
相关论文
共 50 条
  • [31] Image cytometric analysis of p53 and mdm-2 expression in primary and recurrent mucoepidermoid carcinoma of parotid gland: immunohistochemical study
    Abd-Elhamid, Ehab S.
    Elmalahy, Mohamed H.
    DIAGNOSTIC PATHOLOGY, 2010, 5
  • [32] Dedifferentiated Liposarcoma With Meningothelial-like Whorls, Metaplastic Bone Formation, and CDK4, MDM2, and p16 Expression: A Morphologic and Immunohistochemical Study
    Thway, Khin
    Robertson, David
    Thway, Yi
    Fisher, Cyril
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (03) : 356 - 363
  • [33] Expression of mdm-2 protein in neoplastic, preneoplastic, and normal bronchial mucosa specimens: Comparative study with p53 expression
    Rasidakis, A
    Orphanidou, D
    Kalomenidis, J
    Papamichalis, G
    Toumbis, M
    Lambaditis, J
    Sacharidou, A
    Papastamatiou, H
    Jordanoglou, J
    HYBRIDOMA, 1998, 17 (04): : 339 - 345
  • [34] Diagnostic Utility and Limitations of Immunohistochemistry of p16, CDK4, and MDM2 and Automated Dual-color In Situ Hybridization of MDM2 for the Diagnosis of Challenging Cases of Dedifferentiated Liposarcoma
    Kobayashi, Anna
    Sakuma, Toshiko
    Fujimoto, Masayo
    Jimbo, Naoe
    Hirose, Takanori
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (10) : 758 - 763
  • [35] MDM2 Amplification Status and Its Diagnostic Utility In Myxofibrosarcoma: A Clinicopathologic Analysis of 21 Cases
    Dashti, Nooshin Karamzadeh
    Knutson, Darlene
    Kloft-Nelson, Sara
    Greipp, Patricia
    Fritchie, Karen
    MODERN PATHOLOGY, 2019, 32
  • [36] MDM2 Amplification Status and Its Diagnostic Utility In Myxofibrosarcoma: A Clinicopathologic Analysis of 21 Cases
    Dashti, Nooshin Karamzadeh
    Knutson, Darlene
    Kloft-Nelson, Sara
    Greipp, Patricia
    Fritchie, Karen
    LABORATORY INVESTIGATION, 2019, 99
  • [37] Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma A Genetic Study of 22 Cases With Clinicopathologic Analysis
    He, Xin
    Pang, Zongguo
    Zhang, Xianliang
    Lan, Ting
    Chen, Huijiao
    Chen, Min
    Yang, Hong
    Huang, Juan
    Chen, Yihua
    Zhang, Zhang
    Jing, Wenyi
    Peng, Ran
    Zhang, Hongying
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (09) : 1143 - 1155
  • [38] Molar and Nonmolar Hydropic Conceptions with Divergent p57 Expression: A Clinicopathologic Study of 29 Cases
    Fukunaga, Masaharu
    LABORATORY INVESTIGATION, 2023, 103 (03) : S905 - S906
  • [39] Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours
    Aleixo, P. B.
    Hartmann, A. A.
    Menezes, I. C.
    Meurer, R. T.
    Oliveira, A. M.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (12) : 1127 - 1135
  • [40] Milademetan, an oral MDM2 inhibitor, in well-differentiated/dedifferentiated liposarcoma: results from a phase 1 study in patients with solid tumors or lymphomas
    Gounder, M. M.
    Bauer, T. M.
    Schwartz, G. K.
    LoRusso, P.
    Kumar, P.
    Kato, K.
    Tao, B.
    Hong, Y.
    Patel, P.
    Hong, D.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S3 - S4
12345